Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Gynecology | Reproductive Medicine | Research | Medical Students | News

Back to Health News

Study Explores Possibility of a Female Viagra

Last Updated: April 14, 2010.

 

Research in animals may lead to treatment for women with sexual disorder

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Research in animals may lead to treatment for women with sexual disorder.

WEDNESDAY, April 14 (HealthDay News) -- New research might be bringing science a bit closer to a female version of Viagra.

In a study that explored the underlying processes of female sexual arousal, British-based researchers say they have learned more about how new treatments might be developed to help women with sexual arousal disorder.

In tests on female lab animals, a team from the drug maker Pfizer found that electrical stimulation of the pelvic nerve increases blood flow to the genitalia. This effect was enhanced if the animals were given an experimental drug called UK-414,495, which is believed to block the breakdown of a chemical messenger that plays a crucial role in increasing blood flow during sexual arousal.

Blood flow to the vagina, labia and clitoris increases when a woman is sexually aroused. The increased blood flow causes the organs to swell and the vagina to relax, and also increases vaginal lubrication and genitalia sensitivity, according to background information in a news release about the study.

"Before this work, we knew surprisingly little about the processes that control all of these changes," lead researcher Chris Wayman said in the news release. "Now [that] we are beginning to establish the pathways involved in sexual arousal, scientists may be able to find ways of helping women who would like to overcome FSAD [female sexual arousal disorder]."

Women with FSAD find arousal difficult and their genital organs don't respond to sexual stimulation. The condition affects up to 40 percent of women of all ages, the study authors said.

"While the particular chemical compound studied in this research did not prove appropriate for further development, the implications of the research could lead to the development of a product in future," Wayman said in the news release.

The study findings were published in the April 13 online edition of the British Journal of Pharmacology.

More information

The American Academy of Family Physicians has more about female sexual dysfunction.

SOURCE: British Journal of Pharmacology, news release, April 13, 2010

Copyright © 2010 HealthDay. All rights reserved.


Previous: Depression and Smoking Go Hand in Hand in U.S. Next: Test May Measure Suicidal Tendencies

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.